IDXX
IDEXX LABORATORIES INC /DE
Overview
IDEXX Laboratories manufactures and distributes diagnostic instruments, consumables, and software for veterinary practices, livestock and dairy producers, and water testing laboratories.
IDEXX LABORATORIES INC /DE is a Healthcare company operating in Diagnostics & Research with a $43.05B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 2, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-059 Q&A exchanges
- Q4 FY2025Earnings2026-02-0213 Q&A exchanges
- Q3 FY2025Earnings2025-11-0314 Q&A exchanges
- Q2 FY2025Earnings2025-08-0413 Q&A exchanges
- Q1 FY2025Earnings2025-05-0116 Q&A exchanges
- Q4 FY2024Earnings2025-02-0313 Q&A exchanges
- Q3 FY2024Earnings2024-10-3110 Q&A exchanges
- Q2 FY2024Earnings2024-08-067 Q&A exchanges
- Q1 FY2024Earnings2024-05-0115 Q&A exchanges
- Q4 FY2023Earnings2024-02-0511 Q&A exchanges
- Q3 FY2023Earnings2023-11-0118 Q&A exchanges
- Q2 FY2023Earnings2023-08-0117 Q&A exchanges
- Q1 FY2023Earnings2023-05-0220 Q&A exchanges
- Q4 FY2022Earnings2023-02-0615 Q&A exchanges
- Q3 FY2022Earnings2022-11-0118 Q&A exchanges
- Q2 FY2022Earnings2022-08-0214 Q&A exchanges
- Q1 FY2022Earnings2022-05-0410 Q&A exchanges
- Q4 FY2021Earnings2022-02-0217 Q&A exchanges
- Q3 FY2021Earnings2021-11-0220 Q&A exchanges
- Q2 FY2021Earnings2021-07-3020 Q&A exchanges
- Q1 FY2021Earnings2021-05-0411 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-02EPS— vs $3.94—Rev— vs ——EODHD
- Q1 FY20262026-05-04EPS$3.47 vs $3.41+1.8%Rev$1.14B vs ——EODHD
- Q4 FY20252026-02-01EPS$3.08 vs $2.94+4.8%Rev$1.09B vs ——EODHD
- Q3 FY20252025-11-02EPS$3.40 vs $3.15+7.9%Rev$1.11B vs ——EODHD
- Q2 FY20252025-08-03EPS$3.63 vs $3.30+10.0%Rev$1.11B vs ——EODHD
- Q1 FY20252025-04-30EPS$2.96 vs $2.85+3.9%Rev$998.4M vs ——EODHD
- Q4 FY20242025-02-02EPS$2.62 vs $2.40+9.2%Rev$954.3M vs ——EODHD
- Q3 FY20242024-10-30EPS$2.80 vs $2.69+4.1%Rev$975.5M vs ——EODHD
- Q2 FY20242024-08-05EPS$3.02 vs $2.87+5.2%Rev$1.00B vs ——EODHD
- Q1 FY20242024-04-30EPS$2.81 vs $2.67+5.2%Rev$964.1M vs ——EODHD
- Q4 FY20232024-02-04EPS$2.32 vs $2.12+9.4%Rev$901.6M vs ——EODHD
- Q3 FY20232023-10-31EPS$2.53 vs $2.37+6.8%Rev$915.5M vs ——EODHD
- Q2 FY20232023-07-31EPS$2.67 vs $2.47+8.1%Rev$943.6M vs ——EODHD
- Q1 FY20232023-05-01EPS$2.55 vs $2.43+4.9%Rev$900.2M vs ——EODHD
- Q4 FY20222023-02-05EPS$2.05 vs $1.92+6.8%Rev$828.6M vs ——EODHD
- Q3 FY20222022-10-31EPS$2.15 vs $2.04+5.4%Rev$841.7M vs ——EODHD
- Q2 FY20222022-08-01EPS$1.56 vs $1.63-4.3%Rev$860.5M vs ——EODHD
- Q1 FY20222022-05-03EPS$2.27 vs $2.25+0.9%Rev$836.5M vs ——EODHD
- Q4 FY20212022-02-01EPS$1.89 vs $1.72+9.9%Rev$801.1M vs ——EODHD
- Q3 FY20212021-11-01EPS$2.03 vs $1.91+6.3%Rev$810.4M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-02 | — | $3.94 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-04 | $3.47 | $3.41 | +1.8% | $1.14B | — | — | EODHD |
| Q4 FY2025 | 2026-02-01 | $3.08 | $2.94 | +4.8% | $1.09B | — | — | EODHD |
| Q3 FY2025 | 2025-11-02 | $3.40 | $3.15 | +7.9% | $1.11B | — | — | EODHD |
| Q2 FY2025 | 2025-08-03 | $3.63 | $3.30 | +10.0% | $1.11B | — | — | EODHD |
| Q1 FY2025 | 2025-04-30 | $2.96 | $2.85 | +3.9% | $998.4M | — | — | EODHD |
| Q4 FY2024 | 2025-02-02 | $2.62 | $2.40 | +9.2% | $954.3M | — | — | EODHD |
| Q3 FY2024 | 2024-10-30 | $2.80 | $2.69 | +4.1% | $975.5M | — | — | EODHD |
| Q2 FY2024 | 2024-08-05 | $3.02 | $2.87 | +5.2% | $1.00B | — | — | EODHD |
| Q1 FY2024 | 2024-04-30 | $2.81 | $2.67 | +5.2% | $964.1M | — | — | EODHD |
| Q4 FY2023 | 2024-02-04 | $2.32 | $2.12 | +9.4% | $901.6M | — | — | EODHD |
| Q3 FY2023 | 2023-10-31 | $2.53 | $2.37 | +6.8% | $915.5M | — | — | EODHD |
| Q2 FY2023 | 2023-07-31 | $2.67 | $2.47 | +8.1% | $943.6M | — | — | EODHD |
| Q1 FY2023 | 2023-05-01 | $2.55 | $2.43 | +4.9% | $900.2M | — | — | EODHD |
| Q4 FY2022 | 2023-02-05 | $2.05 | $1.92 | +6.8% | $828.6M | — | — | EODHD |
| Q3 FY2022 | 2022-10-31 | $2.15 | $2.04 | +5.4% | $841.7M | — | — | EODHD |
| Q2 FY2022 | 2022-08-01 | $1.56 | $1.63 | -4.3% | $860.5M | — | — | EODHD |
| Q1 FY2022 | 2022-05-03 | $2.27 | $2.25 | +0.9% | $836.5M | — | — | EODHD |
| Q4 FY2021 | 2022-02-01 | $1.89 | $1.72 | +9.9% | $801.1M | — | — | EODHD |
| Q3 FY2021 | 2021-11-01 | $2.03 | $1.91 | +6.3% | $810.4M | — | — | EODHD |
Source: EODHD. IDXX reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks IDXX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 70% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.68 | $2.82 | +30.6% | -4.3% | -5.1% |
| Q4 FY2026 | $4.03 | $3.10 | +30.0% | +0.2% | -2.4% |
| Q3 FY2026 | $3.42 | $2.85 | +20.1% | +0.7% | -0.4% |
| Q2 FY2026 | $3.89 | $3.11 | +25.0% | -7.2% | -5.7% |
| Q1 FY2025 | $4.15 | $3.15 | +31.6% | -8.0% | -9.4% |
| Q4 FY2025 | $3.82 | $2.90 | +31.7% | -8.3% | -6.1% |
| Q3 FY2025 | $3.83 | $3.10 | +23.7% | -8.0% | -7.5% |
| Q2 FY2025 | $4.14 | $3.14 | +31.8% | -2.4% | -2.0% |
| Q1 FY2024 | $3.82 | $3.03 | +26.2% | +2.5% | +5.1% |
| Q4 FY2024 | $3.80 | $3.21 | +18.5% | -7.0% | -8.6% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Jonathan Jay MazelskyCEO10 mono recorded callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last guidance raise Q2 FY2026
- Andrew EmersonCFO10 mo6 callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • last call held guidance Q2 FY2026
- Sharon E UnderbergEVP, GC & Corporate Secretary10 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 2/4 beats (50%) • guidance suspended Q1 FY2026
- Michael Perkins JohnsonExecutive Vice President4 mono recorded callsCurrentSample
OTHER since 2026 • 2/2 beats (100%) • last guidance raise Q3 FY2026
- Michael SchreckExecutive Vice President4 mono recorded callsCurrentSample
OTHER since 2026 • 1/2 beats (50%) • guidance suspended Q2 FY2026
- George FennellExecutive Vice President4 mono recorded callsCurrentSample
OTHER since 2026 • 1/2 beats (50%) • last call held guidance Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for IDXX.
$ curl https://api.spokenalpha.com/v1/companies/IDXXFAQ
Frequently asked about IDXX
Where can I find IDEXX LABORATORIES INC /DE's (IDXX) earnings call transcripts?
Spoken Alpha indexes IDXX's earnings call transcripts at https://spokenalpha.com/companies/IDXX. Each call links to attributed speakers and parsed analyst Q&A. IDEXX LABORATORIES INC /DE's own investor relations page is at https://ir.idexx.com/.
When was IDEXX LABORATORIES INC /DE's most recent earnings call?
IDEXX LABORATORIES INC /DE (IDXX) held its most recent earnings call on 2026-05-05, covering fiscal Q1 2026.
What sector is IDXX in?
IDEXX LABORATORIES INC /DE (IDXX) operates in the Healthcare sector (Diagnostics & Research industry).